Keana; John F. W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Keana; John F. W..The latest application filed is for "analogs of fexaramine and methods of making and using".

Company Profile

9.52.25

Keana; John F. W. - Eugene OR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Analogs of fexaramine and methods of making and using Grant 11,440,889 - Evans , et al. September 13, 2	2022-09-13
PPAR agonists Grant 11,420,934 - Evans , et al. August 23, 2	2022-08-23
Analogs Of Fexaramine And Methods Of Making And Using App 20210147365 - Evans; Ronald M. ; et al.	2021-05-20
Analogs of fexaramine and methods of making and using Grant 10,815,203 - Evans , et al. October 27, 2	2020-10-27
Ppar Agonists App 20200190019 - Evans; Ronald M. ; et al.	2020-06-18
Analogs Of Fexaramine And Methods Of Making And Using App 20200123113 - Evans; Ronald M. ; et al.	2020-04-23
PPAR agonists Grant 10,550,071 - Evans , et al. Fe	2020-02-04
Analogs of fexaramine and methods of making and using Grant 10,450,277 - Evans , et al. Oc	2019-10-22
Analogs of fexaramine and methods of making and using Grant 10,301,268 - Evans , et al.	2019-05-28
Analogs Of Fexaramine And Methods Of Making And Using App 20190084939 - Evans; Ronald M. ; et al.	2019-03-21
FXR agonists and methods for making and using Grant 10,077,268 - Evans , et al. September 18, 2	2018-09-18
Ppar Agonists App 20180170857 - Evans; Ronald M. ; et al.	2018-06-21
PPAR agonists Grant 9,938,234 - Evans , et al. April 10, 2	2018-04-10
Analogs Of Fexaramine And Methods Of Making And Using App 20170066724 - Evans; Ronald M. ; et al.	2017-03-09
Fxr Agonists And Methods For Making And Using App 20160376279 - Evans; Ronald M. ; et al.	2016-12-29
Ppar Agonists App 20160023991 - Evans; Ronald M. ; et al.	2016-01-28
Treatment of hyperproliferative diseases with vinca alkaloid N-oxide analogs Grant 8,883,775 - Curd , et al. November 11, 2	2014-11-11
Mannich base N-oxide drugs Grant 8,410,075 - Keana , et al. April 2, 2	2013-04-02
Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide Analogs App 20120107230 - CURD; JOHN G. ; et al.	2012-05-03
Treatment of hyperproliferative diseases with vinca alkaloid N-oxide and analogs Grant 8,048,872 - Curd , et al. November 1, 2	2011-11-01
Novel Compounds and Methods of Using Them App 20100298270 - Keana; John F.W. ; et al.	2010-11-25
Novel Compounds and Methods of Using Them App 20100267779 - Keana; John F.W. ; et al.	2010-10-21
Mannich Base N-Oxide Drugs App 20100016252 - Keana; John F.W. ; et al.	2010-01-21
Production of gossypol co-crystals Grant 7,557,251 - Wang , et al. July 7, 2	2009-07-07
1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof App 20080305082 - Curd; John G. ; et al.	2008-12-11
Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide and Analogs App 20080305075 - Curd; John G. ; et al.	2008-12-11
Kw-3902 Conjugates That Do Not Cross The Blood-brain Barrier App 20080070934 - Mugerditichian; Mark ; et al.	2008-03-20
Production of gossypol co-crystals App 20080021110 - Wang; Shaomeng ; et al.	2008-01-24
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof Grant 7,270,801 - Weber , et al. September 18, 2	2007-09-18
Dipeptide apoptosis inhibitors and the use thereof Grant 6,949,516 - Keana , et al. September 27, 2	2005-09-27
Dipeptide apoptosis inhibitors and the use thereof App 20050192231 - Keana, John F.W. ; et al.	2005-09-01
Substituted 5-oxo-5, 6, 7, 8-tetrahydro-4H-1-benzopyrans Grant 6,800,657 - Konkoy , et al. October 5, 2	2004-10-05
Novel fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof App 20040191844 - Weber, Eckard ; et al.	2004-09-30
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof Grant 6,759,207 - Weber , et al. July 6, 2	2004-07-06
Substituted 5-oxo-5, 6, 7, 8-tetrahydro-4h-1-benzopyrans App 20040097581 - Konkoy, Christopher S. ; et al.	2004-05-20
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof Grant 6,696,442 - Wang , et al. February 24, 2	2004-02-24
Substituted 5-oxo-5,6,7,8-tetrahydro-4H-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of AMPA Grant 6,680,332 - Konkoy , et al. January 20, 2	2004-01-20
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof Grant 6,638,947 - Wang , et al. October 28, 2	2003-10-28
Dipeptide apoptosis inhibitors and the use thereof App 20030181391 - Keana, John F.W. ; et al.	2003-09-25
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof Grant 6,613,803 - Wang , et al. September 2, 2	2003-09-02
Subtype-selective NMDA receptor ligands and the use thereof App 20030144319 - Bigge, Christopher F. ; et al.	2003-07-31
Dipeptide apoptosis inhibitors and the thereof Grant 6,596,693 - Keana , et al. July 22, 2	2003-07-22
4-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonists App 20030105133 - Bigge, Christopher F. ; et al.	2003-06-05
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof App 20020183321 - Wang, Yan ; et al.	2002-12-05
Novel fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof App 20020150885 - Weber, Eckard ; et al.	2002-10-17
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof Grant 6,342,611 - Weber , et al. January 29, 2	2002-01-29
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof Grant 6,335,429 - Cai , et al. January 1, 2	2002-01-01
Subtype-selective NMDA receptor ligands and the use thereof App 20010051633 - Bigge, Christopher F. ; et al.	2001-12-13
Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists Grant 6,251,948 - Weber , et al. June 26, 2	2001-06-26
Subtype-selective NMDA receptor ligands and the use thereof Grant 6,218,404 - Bigge , et al. April 17, 2	2001-04-17
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists Grant 6,130,234 - Bigge , et al. October 10, 2	2000-10-10
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists Grant 6,124,323 - Bigge , et al. September 26, 2	2000-09-26
2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists Grant 6,124,317 - Bigge , et al. September 26, 2	2000-09-26
Chemical functionalization of surfaces Grant 6,022,597 - Yan , et al. February 8, 2	2000-02-08
Methods for functionalizing and coating substrates and devices made according to the methods Grant 5,830,539 - Yan , et al. November 3, 1	1998-11-03
Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones Grant 5,631,373 - Cai , et al. May 20, 1	1997-05-20
Glycine receptor antagonists and the use thereof Grant 5,620,979 - Weber , et al. April 15, 1	1997-04-15
Glycine receptor antagonist pharmacophore Grant 5,597,922 - Cai , et al. January 28, 1	1997-01-28
Molecularly imprinted materials, method for their preparation and devices employing such materials Grant 5,587,273 - Yan , et al. December 24, 1	1996-12-24
Chemical functionalization of surfaces Grant 5,582,955 - Keana , et al. December 10, 1	1996-12-10
Chemical functionalization of surfaces Grant 5,580,697 - Keana , et al. December 3, 1	1996-12-03
Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group Grant 5,567,411 - Keana , et al. October 22, 1	1996-10-22
Glycine receptor antagonists and the use thereof Grant 5,514,680 - Weber , et al. May 7, 1	1996-05-07
Azepine synthesis via a diels-alder reaction Grant 5,476,933 - Keana , et al. December 19, 1	1995-12-19
1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and the use thereof Grant 5,475,007 - Cai , et al. December 12, 1	1995-12-12
Sensors employing interference of electromagnetic waves passing through waveguides having functionalized surfaces Grant 5,465,151 - Wybourne , et al. November 7, 1	1995-11-07
Amplifier molecules derived from diethylene triaminepentaacetic acid for enhancement of diagnosis and therapy Grant 5,412,148 - Keana May 2, 1	1995-05-02
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists Grant 5,336,689 - Weber , et al. August 9, 1	1994-08-09
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists Grant 5,262,568 - Weber , et al. November 16, 1	1993-11-16
Amplifier molecules for diagnosis and therapy derived from 3,5-bis[1-(3-amino-2,2-bis (aminomethyl)-propyl) oxymethyl] benzoic acid Grant 5,252,317 - Keana October 12, 1	1993-10-12
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists Grant 5,190,976 - Weber , et al. March 2, 1	1993-03-02
Amplifier molecules for enhancement of diagnosis and therapy Grant 5,135,737 - Keana August 4, 1	1992-08-04
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists Grant 5,093,525 - Weber , et al. March 3, 1	1992-03-03
Methods for circumventing the problem of free radial reduction associated with the use of stable nitroxide free radicals as contrast agents for magnetic reasonance imaging Grant 4,863,717 - Keana September 5, 1	1989-09-05
Proxyl nitroxides as spin labels Grant 4,099,918 - Keana July 11, 1	1978-07-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.